- Home
- RELY vs TMDX Comparison
RELY vs TMDX Comparison
Compare RELY & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RELY
- TMDX
- Stock Information
- Founded
- RELY 2011
- TMDX 1998
- Country
- RELY United States
- TMDX United States
- Employees
- RELY N/A
- TMDX N/A
- Industry
- RELY Computer Software: Prepackaged Software
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- RELY Technology
- TMDX Health Care
- Exchange
- RELY Nasdaq
- TMDX Nasdaq
- Market Cap
- RELY 3.8B
- TMDX 4.0B
- IPO Year
- RELY 2021
- TMDX 2019
- Fundamental
- Price
- RELY $12.73
- TMDX $119.03
- Analyst Decision
- RELY Buy
- TMDX Buy
- Analyst Count
- RELY 10
- TMDX 11
- Target Price
- RELY $26.00
- TMDX $130.73
- AVG Volume (30 Days)
- RELY 4.5M
- TMDX 1.1M
- Earning Date
- RELY 11-05-2025
- TMDX 10-29-2025
- Dividend Yield
- RELY N/A
- TMDX N/A
- EPS Growth
- RELY N/A
- TMDX 170.70
- EPS
- RELY 0.09
- TMDX 2.54
- Revenue
- RELY $1,544,865,000.00
- TMDX $566,354,000.00
- Revenue This Year
- RELY $30.54
- TMDX $38.84
- Revenue Next Year
- RELY $19.94
- TMDX $20.46
- P/E Ratio
- RELY $134.86
- TMDX $46.95
- Revenue Growth
- RELY 31.27
- TMDX 41.20
- 52 Week Low
- RELY $12.17
- TMDX $55.00
- 52 Week High
- RELY $27.32
- TMDX $145.50
- Technical
- Relative Strength Index (RSI)
- RELY 27.46
- TMDX 44.82
- Support Level
- RELY $15.76
- TMDX $119.20
- Resistance Level
- RELY $16.75
- TMDX $128.09
- Average True Range (ATR)
- RELY 0.53
- TMDX 7.95
- MACD
- RELY -0.33
- TMDX -0.93
- Stochastic Oscillator
- RELY 7.99
- TMDX 12.28
About RELY Remitly Global Inc.
Remitly Global Inc provides integrated financial services to immigrants, including helping customers send money internationally in a quick, reliable, and more cost-effective manner by leveraging digital channels. It supports cross-border transmissions across the globe. The company's revenue is generated on transaction fees charged to customers and foreign exchange spreads between the foreign exchange rate offered to customers and the foreign exchange rate on the company's currency purchases.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.